Aclarubicin hydrochloride for injection (ACR) is a kind of antitumor antibiotic developed by Professor H. Umezawa of Micro-biochemistry Research Center of Japan. It has been applied for got compounds patent of Japan. It is applied to cure acute leukemia and malignant lymphoma, and when it was tried to cure other solid tumor, we got certain clinical curative effects.
Aclarubicin is a breed of "Catalogue of National Essential Drugs". Use imported high-quality feedstock and advanced productive technique, the aclarubicins produced by our corporation have high performance and adequate quality. They are generally accepted by most clinicians and patients.
